<i>SLC7A8</i> coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.

Front Pharmacol · 2022 · PMC9681801 · PMID 36438828

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although not significant, p-mTOR expression showed a trend towards poorer DFS (p DFS = 0.08, p OS = 0.92, Supplementary Figure S5 ) and LAT2 expression may improve DFS and overall survival, however this was neither significant (p DFS = 0.15, p OS = 0.081, Supplementary Figure S5 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.